Biotech

Biohaven Pharmaceuticals

1

Articles

Competitor

Top Role

Apr 11, 2026

First Mention

Apr 11, 2026

Last Mention

0.95

Relevance Score

Coverage Timeline

April 2026

After Xeljanz: How Pfizer Plans to Fill a $2B Hole Post-2025 Patent Cliff Data Competitor

Apr 11, 2026

Zavzpret faces a migraine market already jostling with AbbVie’s Nurtec and Biohaven’s rimegepant.